Wei Dong Jiang
Founder bij SHANGHAI HENLIUS BIOTECH, INC.
Vermogen: 1 M $ op 31-03-2024
Profiel
Wei Dong Jiang is the founder of two companies, Henlius Biopharmaceuticals, Inc. and Shanghai Henlius Biotech, Inc., both founded in 2009.
He held the title of Chief Scientific Officer & Vice President at Henlius Biopharmaceuticals, Inc. and Chief Scientific Officer & Senior Vice President at Shanghai Henlius Biotech, Inc. Dr. Jiang has a doctorate degree from the University of Giessen and an undergraduate degree from Zhejiang University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-06-2023 | 720 955 ( 0.44% ) | 1 M $ | 31-03-2024 |
Actieve functies van Wei Dong Jiang
| Bedrijven | Functie | Begin |
|---|---|---|
| SHANGHAI HENLIUS BIOTECH, INC. | Founder | 01-12-2009 |
Eerdere bekende functies van Wei Dong Jiang
| Bedrijven | Functie | Einde |
|---|---|---|
Henlius Biopharmaceuticals, Inc.
 Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Founder | - |
Opleiding van Wei Dong Jiang
| University of Giessen | Doctorate Degree |
| Zhejiang University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SHANGHAI HENLIUS BIOTECH, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Henlius Biopharmaceuticals, Inc.
Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Health Technology |
